Senl-T7 Clinical Trials

1 actively recruiting trial

Top Sponsors

Hebei Senlang Biotechnology Inc., Ltd.1

Indications

T-cell Acute Lymphoblastic Leukemia/Lymphoma1
Cancer1

Other1 trial

Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBL

N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.